Literature DB >> 7737724

A noninvasive computerized tail-cuff system for measuring blood pressure in mice.

J H Krege1, J B Hodgin, J R Hagaman, O Smithies.   

Abstract

We have validated a noninvasive computerized tail-cuff system for measuring blood pressure in mice. The system was designed to perform all functions automatically, including a programmable routine of cuff inflation and deflation, analysis and assignment of pulse rate and blood pressure, and recording of data electronically. To evaluate this system over a range of blood pressures, we gave groups of mice enalapril or NG-nitro-L-arginine methyl ester in their drinking water. For each of these groups, an equal number of control mice were given nothing in their drinking water. Tail-cuff blood pressures were recorded as the means of blood pressures determined on at least 3 days after at least 7 days of training. Tail-cuff enalapril and control group means were measured both 3 and 4 months after enalapril (or no drug) was begun; the group means at 3 months were not significantly different from the group means at 4 months. These results demonstrate that the system gives reproducible results. After the tail-cuff measurements were completed, intra-arterial blood pressures were attempted in all mice under unrestrained, unanesthetized conditions, and individual mouse (n = 22) blood pressures with the use of the two methods were compared. The blood pressures from individual mice by tail-cuff and intra-arterial methods were highly correlated (r = .86, P < .01). The means for the four mouse groups were also highly correlated (r = .98, P < .02).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 7737724     DOI: 10.1161/01.hyp.25.5.1111

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  181 in total

1.  IgG receptor FcγRIIB plays a key role in obesity-induced hypertension.

Authors:  Nathan C Sundgren; Wanpen Vongpatanasin; Brigid-Meghan D Boggan; Keiji Tanigaki; Ivan S Yuhanna; Ken L Chambliss; Chieko Mineo; Philip W Shaul
Journal:  Hypertension       Date:  2014-11-03       Impact factor: 10.190

2.  Therapeutic targeting of mitochondrial superoxide in hypertension.

Authors:  Anna E Dikalova; Alfiya T Bikineyeva; Klaudia Budzyn; Rafal R Nazarewicz; Louise McCann; William Lewis; David G Harrison; Sergey I Dikalov
Journal:  Circ Res       Date:  2010-05-06       Impact factor: 17.367

3.  Role of circulating fibroblast growth factor-2 in lipopolysaccharide-induced acute kidney injury in mice.

Authors:  Parnell C Mattison; Angel A Soler-García; Jharna R Das; Marina Jerebtsova; Sofia Perazzo; Pingtao Tang; Patricio E Ray
Journal:  Pediatr Nephrol       Date:  2011-09-30       Impact factor: 3.714

4.  HDACs Regulate miR-133a Expression in Pressure Overload-Induced Cardiac Fibrosis.

Authors:  Ludivine Renaud; Lillianne G Harris; Santhosh K Mani; Harinath Kasiganesan; James C Chou; Catalin F Baicu; An Van Laer; Adam W Akerman; Robert E Stroud; Jeffrey A Jones; Michael R Zile; Donald R Menick
Journal:  Circ Heart Fail       Date:  2015-09-14       Impact factor: 8.790

5.  eNOS deficiency acts through endothelin to aggravate sFlt-1-induced pre-eclampsia-like phenotype.

Authors:  Feng Li; John R Hagaman; Hyung-Suk Kim; Nobuyo Maeda; J Charles Jennette; James E Faber; S Ananth Karumanchi; Oliver Smithies; Nobuyuki Takahashi
Journal:  J Am Soc Nephrol       Date:  2012-01-26       Impact factor: 10.121

6.  mPGES-1 deletion impairs aldosterone escape and enhances sodium appetite.

Authors:  Zhanjun Jia; Toshinori Aoyagi; Donald E Kohan; Tianxin Yang
Journal:  Am J Physiol Renal Physiol       Date:  2010-03-24

7.  Blood pressure in 15 inbred mouse strains and its lack of relation with obesity and insulin resistance in the progeny of an NZO/HILtJ x C3H/HeJ intercross.

Authors:  Chieko Tsukahara; Fumihiro Sugiyama; Beverly Paigen; Satoshi Kunita; Ken-Ichi Yagami
Journal:  Mamm Genome       Date:  2004-12       Impact factor: 2.957

8.  Novel role for retinol-binding protein 4 in the regulation of blood pressure.

Authors:  Bettina J Kraus; Juliano L Sartoretto; Pazit Polak; Tetsuya Hosooka; Takashi Shiroto; Iratxe Eskurza; Seung-Ah Lee; Hongfeng Jiang; Thomas Michel; Barbara B Kahn
Journal:  FASEB J       Date:  2015-04-24       Impact factor: 5.191

9.  Angiotensin II subtype 2 receptor blockade and deficiency attenuate the development of atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes.

Authors:  A Koïtka; Z Cao; P Koh; A M D Watson; K C Sourris; L Loufrani; A Soro-Paavonen; T Walther; K J Woollard; K A M Jandeleit-Dahm; M E Cooper; T J Allen
Journal:  Diabetologia       Date:  2009-12-03       Impact factor: 10.122

10.  Hypertension and abnormal fat distribution but not insulin resistance in mice with P465L PPARgamma.

Authors:  Yau-Sheng Tsai; Hyo-Jeong Kim; Nobuyuki Takahashi; Hyung-Suk Kim; John R Hagaman; Jason K Kim; Nobuyo Maeda
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.